Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction
NCT ID: NCT06153836
Last Updated: 2025-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE2
20 participants
INTERVENTIONAL
2023-12-05
2026-11-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and Reconstruction
NCT01208974
A Pilot Study to Evaluate Nipple-Areolar Complex (NAC) Sparing Mastectomy
NCT00539227
Comparison of Nipple-areolar Complex Sensation According to Incision Types in Nipple-sparing Mastectomy
NCT05917834
Split Chest Breast Neurotization
NCT05757778
Preoperative Evaluation of 3D Reconstruction Tool for Nipple-sparing Mastectomy
NCT06071234
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To determine willingness of patients undergoing NSM to enroll in a randomized trial of NSM with or without neurotization.
SECONDARY OBJECTIVES:
I. To compare patient reported outcomes, including quality of life and breast and NAC sexual functionality, for patients undergoing NSM with or without neurotization.
II. To compare NAC sensation at 12 months in patients undergoing NSM with or without neurotization.
III To determine rate of mastectomy skin flap necrosis following NSM via the skin ischemia and necrosis (SKIN) score.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients undergo standard of care NSM on study.
ARM II: Patients undergo neurotization during standard of care NSM on study.
After completion of study intervention, patients are followed at 14 days and at 6, 12 and 24 months postoperatively.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ARM I (control)
Patients undergo standard of care NSM on study.
Questionnaire Administration
Ancillary studies
Subcutaneous Mastectomy
Undergo standard of care NSM
ARM II (neurotization)
Patients undergo neurotization during standard of care NSM on study.
Neurotization Procedure
Undergo placement of nerve graft
Questionnaire Administration
Ancillary studies
Subcutaneous Mastectomy
Undergo standard of care NSM
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neurotization Procedure
Undergo placement of nerve graft
Questionnaire Administration
Ancillary studies
Subcutaneous Mastectomy
Undergo standard of care NSM
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2
* Planned nipple sparing mastectomy (NSM)
* Ideal NSM candidates would meet the following criteria:
* Cup size A-C
* BMI \<34
* Ptosis grade \< 2
* Clinical stage 0 - T2N0
* Final planned implant volume \< 400cc
* Inframammary or lateral mammary incision
* Tumor \> 0.5cm from the nipple areolar complex (NAC)
* No prior breast reduction, mastopexy, or periareolar incisions on side of planned NSM
* No prior breast radiation on side of planned NSM
* Tumor \<0.5cm from NAC (including suspicious calcifications or MRI enhancement)
* No planned post mastectomy radiation (PMRT)
* No nicotine use within 4 weeks of surgical date
Exclusion Criteria
* Pregnancy
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James W. Jakub, M.D.
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Olivia S. Ho, M.D., M.S.
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic in Florida
Jacksonville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2023-09574
Identifier Type: REGISTRY
Identifier Source: secondary_id
23-004411
Identifier Type: OTHER
Identifier Source: secondary_id
MC230302
Identifier Type: OTHER
Identifier Source: secondary_id
MC230302
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.